Movement of monoglyceride derived from hydrolysis of fluorescence-labeled lyso platelet-activating factor by lysophospholipase C through plasma membranes of porcine kidney epithelial cell line LLC-PK1

Prostaglandins and Other Lipid Mediators

Volumn 83, Issue 1-2, 2007, Pages 33-41

  Tsutsumi, Toshihiko ^a   Morishige, Junichi ^b   Fukuzawa, Kenji ^b   Tokumura, Akira ^b  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Kidney tubule cell; Lipid transport; Lyso platelet activating factor; Lysophospholipase C; Monoglyceride

Indexed keywords

ALKYL ETHER; BOVINE SERUM ALBUMIN; FLUORESCENT DYE; LYSOPHOSPHATIDYLCHOLINE; MONOACYLGLYCEROL; PHOSPHOLIPASE C; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE TRANSPORT; CELL STRAIN; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; ENZYME ACTIVITY; LIPID TRANSPORT; MONOLAYER CULTURE; NONHUMAN; PROTEIN LIPID INTERACTION; PROTEIN SECRETION; SWINE; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BIOLOGICAL TRANSPORT; BORON COMPOUNDS; CELL MEMBRANE; CHROMATOGRAPHY, THIN LAYER; EPITHELIAL CELLS; FLUORESCENT DYES; GLYCERYLPHOSPHORYLCHOLINE; HYDROLYSIS; KIDNEY; LYSOPHOSPHOLIPASE; MONOGLYCERIDES; PLATELET ACTIVATING FACTOR; SWINE;

EID: 33846408012     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.09.007     Document Type: Article

References (23)

1. Sanchez-Crespo M., Inarrea P., Alvarez V., Alonso F., Egido J., and Hernando I. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. Am J Physiol 244 (1983) F706-F711
2. Benfenati E., Macconi D., Noris M., et al. Development of a mass spectrometric method to quantitate platelet activating factor in mouise urine. J Lipid Res 30 (1989) 1977-1981
3. Noris M., Perico N., Macconi D., et al. Renal metabolism and urinary excretion of platelet-activating factor in the rat. J Biol Chem 265 (1990) 19414-19419
4. Benigni A., Boccardo P., Noris M., Remuzzi G., and Siegler R.L. Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome. Lancet 339 (1992) 835-836
5. Quinn M.T., Parthasarathy S., and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85 (1988) 2805-2809
6. 3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis. Kidney Int 44 (1993) 747-754
7. Ernest S., and Bello-Reuss E. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. J Am Soc Nephrol 10 (1999) 2306-2313
8. Tokumura A., Tsutsumi T., Yoshida J., and Tsukatani H. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea pig leukocytes. Biochim Biophys Acta 1044 (1990) 91-100
9. Tokumura A., Tsutsumi T., Nishioka Y., and Tsukatani H. Exogenously added alkylmethylglycerophosphocholine and alkylmethylcarbamylglycerophosphocholine accumulate in plasma membranes more than in intracellular membranes of rabbit platelets. Chem Phys Lipids 86 (1997) 5-83
10. Tsutsumi T., Tokumura A., and Kitazawa S. Undifferentiated HL-60 cells internalize an antitumor alkyl ether phospholipid more rapidly than resistant 562 K cells. Biochim Biophys Acta 1390 (1998) 73-84
11. Tsutsumi T., Tokumura A., Yamaguchi M., Kitazawa S., and Tanigawara Y. Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells: relevance to the release of lipid. Biol Pharm Bull 27 (2004) 24-28
12. Tanigawara Y., Okamura N., Hirai M., et al. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 263 (1992) 840-845
13. Nevo N., Chossat N., Gosgnach W., Logert D., Mercadier J.J., and Michel J.B. Increasing endothelial cell permeability improves the efficiency of myocyte adenoviral vector infection. J Gene Med 3 (2001) 42-50
14. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
15. Simon M.F., Rey A., Castan-Laurel I., et al. Expression of ectolipid phosphate phosphohydrolases in 3T3F442A. Involvement in the control of lysophosphatidic acid production. J Biol Chem 277 (2002) 23131-23136
16. Tanaka M., Kishi Y., Takanezawa Y., Kakehi Y., Aoki J., and Arai H. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett 571 (2004) 197-204
17. Muller-Decker K. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem Biophys Res Commun 162 (1989) 198-205
18. Lansmann S., Schutte C.G., Bartelsen O., et al. Human acid sphingomyelinase. Eur J Biochem 270 (2003) 1076-1088
19. Sawai H., Domae N., Nagan N., and Hannun Y.A. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J Biol Chem 274 (1999) 38131-38139
20. Sakagami H., Aoki J., Natori Y., et al. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. J Biol Chem 280 (2004) 2308-23093
21. Kanfer J.N., and McCartney D.G. GPC phosphodiesterase and phosphomonoesterase activities of renal cortex and medulla of control, antidiuresis and diuresis rats. FEBS Lett 257 (1989) 348-350
22. Zablocki K., Miller S.P.F., Garcia-Perez A., and Burg M.B. Accumulation of glycerophosphocholine (GPC) by renal cells: Osmotic regulation of GPC:choline phosphodiesterase. Proc Natl Acad Sci USA 88 (1991) 7820-7824
23. Wirthensohn G., Beck F.X., and Guder W.G. Role and regulation of glycerophosphorylcholine in rat renal papilla. Pflugers Arch 409 (1987) 411-415